Health CareMedical Equipment and Services
  • Price (USD)140.06
  • Today's Change4.67 / 3.45%
  • Shares traded1.67m
  • 1 Year change-1.36%
  • Beta0.9445
Data delayed at least 15 minutes, as of Mar 24 2023 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, consumers, and accountable care organizations (ACOs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology business, which offers solutions for healthcare providers. The Company’s services are primarily provided under the Quest Diagnostics brand and also provide services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

  • Revenue in USD (TTM)9.88bn
  • Net income in USD942.00m
  • Incorporated1996
  • Employees40.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DGX:NYQ since
Newyork-Presbyterian Hospital-Laboratory Services BusinessAnnounced14 Feb 202314 Feb 2023Announced-4.25%--
Northern Light LaboratoryDeal completed08 Dec 202208 Dec 2022Deal completed-6.00%--
LabCare PLUSAnnounced05 Oct 202205 Oct 2022Announced9.34%--
Data delayed at least 15 minutes, as of Mar 24 2023 20:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Chemed Corporation2.13bn249.62m7.76bn14.17k31.429.6725.143.6416.5316.53141.3953.701.53134.4315.44150,699.7017.9320.3622.8525.7735.8433.8211.6912.540.882781.930.10888.20-0.20095.08-7.0522.67-2.27--
Universal Health Services, Inc.13.40bn674.86m8.64bn71.20k13.351.466.970.64479.169.16181.4883.831.01--7.12188,193.404.946.845.838.13----4.907.061.217.910.44615.545.995.18-31.80-1.344.5914.87
Oak Street Health Inc2.16bn-509.30m8.64bn3.80k------4.00-2.21-2.219.39-1.121.11--2.97---26.17-30.93-45.11-55.063.613.89-23.59-24.40---184.201.38--50.8463.49-24.38--47.39--
Agilon Health Inc2.71bn-107.02m11.48bn747.00--11.01--4.24-0.2605-0.25946.552.521.65--6.853,625,450.00-6.54---8.97--11.39---3.96-----26.070.0401--47.70--73.59------
Quest Diagnostics Inc9.88bn942.00m14.95bn40.00k16.972.5310.621.517.917.9183.5853.090.747432.097.51247,075.007.349.438.4810.9835.0637.139.8213.131.1010.990.398524.95-8.395.95-52.627.289.907.63
Molina Healthcare Inc31.97bn792.00m15.45bn15.00k19.575.1915.960.483113.5413.54546.8051.102.61--14.282,131,600.006.467.7414.9117.5415.0116.352.483.11--13.080.44650.0015.139.9720.18--1.14--
Laboratory Corp. of America Holdings14.88bn1.28bn19.20bn80.00k15.681.9010.031.2913.8413.84162.32114.470.733924.064.96185,960.006.327.497.398.7229.4831.528.6110.271.3511.170.3493---7.727.61-46.2012.558.85--
Data as of Mar 24 2023. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

37.10%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202213.50m12.13%
BlackRock Fund Advisorsas of 31 Dec 20227.30m6.56%
SSgA Funds Management, Inc.as of 31 Dec 20225.86m5.26%
Victory Capital Management, Inc. (Investment Management)as of 31 Dec 20223.26m2.93%
Geode Capital Management LLCas of 31 Dec 20222.36m2.12%
Dimensional Fund Advisors LPas of 31 Dec 20222.04m1.83%
Davis Selected Advisers LPas of 31 Dec 20221.84m1.65%
Invesco Capital Management LLCas of 31 Dec 20221.77m1.59%
BlackRock Investment Management (UK) Ltd.as of 31 Dec 20221.69m1.52%
American Century Investment Management, Inc.as of 31 Dec 20221.68m1.51%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.